DEA reschedules Epidiolex, marijuana-derived drug, paving the way for it to hit the market
This paves the way for GW Pharmaceuticals to start selling the first FDA-approved drug that's derived from cannabis, but the DEA stopped short of reclassifying all cannabidiol products.
from Business News https://ift.tt/2QfQCXJ
from Business News https://ift.tt/2QfQCXJ
0 Response to "DEA reschedules Epidiolex, marijuana-derived drug, paving the way for it to hit the market"
Post a Comment